Alemtuzumab in the up-front setting

Matthew Kaufman, Kanti R RaiLong Island Jewish Medical Center, New Hyde Park, NY, USAAbstract: Alemtuzumab is a humanized chimeric monoclonal antibody targeting CD52. Although this agent already has an important role in the treatment of chronic lymphocytic leukemia (CLL), many of its uses are still...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew Kaufman (Author), Kanti R Rai (Author)
Format: Book
Published: Dove Medical Press, 2008-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available